A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699

Clinical trial NCT03953092 · COMPLETED

Trial details

NCT number: NCT03953092
Sponsor: Youngene Therapeutics Inc., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabete Mellitus

Start date: 2019-05-01
Primary completion: 2019-11-13
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.